Skip to content

Swiss National Registry of Adults With Congenital Heart Disease

Nationales Register Zur Erfassung Von Erwachsenen Mit Angeborenen Herzfehlern

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02258724
Acronym
SACHER
Enrollment
5000
Registered
2014-10-07
Start date
2013-09-01
Completion date
2033-12-01
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Defect, Congenital Heart Disease

Keywords

Adult, Registry, Grown-up congenital heart disease

Brief summary

Due to successes in the last decades in pediatric heart surgery and cardiology, 90-95% of the children with congenital heart disease reach adult age.This results in an increasing number of adults or "grown-ups" with congenital heart disease (ACHD or GUCH patients) that require special health care organization and training programmes. Long term complications of these GUCH patients and optimum treatment strategies are still poorly known. The aim of this registry is to collect quantitative and qualitative data regarding GUCH patients treated in specialised centres in Switzerland.

Detailed description

The SWISS GUCH registry will capture epidemiologic data, diagnosis, type of earlier treatment / intervention and cardiac complications. Following each visit, the cardiac complications will be captured as well as the mortality. Every GUCH patient coming for a visit in one of the specialized organisation participating to the registry will be asked to participate. After signing the informed consent form, the patient data will be coded and captured in a web-based data base (secuTrial®). Pooling the data from the different centres will enable a nation wide register to be established. More robust data on the size and composition of the GUCH population will be obtained. Also long term prognosis of specific patient group will be derived.

Interventions

None listed

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult (above 18 years of age) with congenital heart disease, treated in one of the Swiss centre with specialized organisation for GUCH patients. Signed informed consent. Patients with trisomy 21: the parents or legal guardian will have to give the consent.

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frame
Mortality1 year and yearly up to 20 years

Secondary

MeasureTime frameDescription
Cardial complications1 year and yearly up to 20 yearsRequiring in-patient hospitalisation, strokes, re-intervention

Countries

Switzerland

Contacts

CONTACTDaniel Tobler, MD
daniel.tobler@usb.ch+41 61 265 52 14
PRINCIPAL_INVESTIGATORDaniel Tobler, MD

University Hospital, Basel, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 5, 2026